Literature DB >> 26202762

Interobserver reproducibility of the controlled attenuation parameter (CAP) for quantifying liver steatosis.

Giovanna Ferraioli1, Carmine Tinelli2, Raffaella Lissandrin3, Mabel Zicchetti3, Mariangela Rondanelli4, Guido Perani5, Stefano Bernuzzi6, Laura Salvaneschi6, Carlo Filice3.   

Abstract

PURPOSE: This study was conducted to prospectively investigate the interobserver reproducibility of controlled attenuation parameter (CAP) measurements and the relationship among the CAP and body mass index (BMI), gender and age.
METHODS: Consecutive subjects were studied using the M+ probe of the FibroScan device (Echosens, Paris, France). Measurements were performed by two raters (rater1 and rater2). Interobserver agreement was assessed by using the concordance correlation coefficient (CCC). The Pearson r coefficient was used to test correlation between two study variables, and linear regression was used for the multivariate model.
RESULTS: Three hundred fifty-one subjects (227 males and 124 females) were prospectively studied. The CCC was 0.82 (95 % CI 0.78-0.85) overall, 0.80 (95 % CI 0.75-0.85) for BMI <25 kg/m(2), 0.76 (95 % CI 0.69-0.84) for BMI 25-29 kg/m(2) and 0.65 (95 % CI 0.41-0.88) for BMI ≥30 kg/m(2). The CCC was 0.44 (95 % CI 0.31-0.56) for CAP values ≤240 dB/m and 0.72 (95 % CI 0.65-0.79) for CAP values >240 dB/m. In univariate analysis, age and BMI by gender were correlated with the CAP. Multiple regression analysis confirmed the relationship of the CAP with age and BMI, but not with gender.
CONCLUSIONS: The results of this study show that the interreader agreement in CAP measurement is good. In healthy volunteers, the CAP is strongly correlated with age and BMI.

Entities:  

Keywords:  Controlled attenuation parameter; Interobserver agreement; Liver steatosis; Noninvasive techniques; Reproducibility studies; Transient elastography

Year:  2014        PMID: 26202762     DOI: 10.1007/s12072-014-9573-1

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  22 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C.

Authors:  M Sasso; I Tengher-Barna; M Ziol; V Miette; C Fournier; L Sandrin; R Poupon; A-C Cardoso; P Marcellin; C Douvin; V de Ledinghen; J-C Trinchet; M Beaugrand
Journal:  J Viral Hepat       Date:  2011-10-13       Impact factor: 3.728

3.  Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

Authors:  Magali Sasso; Michel Beaugrand; Victor de Ledinghen; Catherine Douvin; Patrick Marcellin; Raoul Poupon; Laurent Sandrin; Véronique Miette
Journal:  Ultrasound Med Biol       Date:  2010-09-27       Impact factor: 2.998

4.  Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease.

Authors:  Mirella Fraquelli; Cristina Rigamonti; Giovanni Casazza; Dario Conte; Maria Francesca Donato; Guido Ronchi; Massimo Colombo
Journal:  Gut       Date:  2007-01-25       Impact factor: 23.059

5.  Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.

Authors:  Victor de Lédinghen; Julien Vergniol; Maylis Capdepont; Faiza Chermak; Jean-Baptiste Hiriart; Christophe Cassinotto; Wassil Merrouche; Juliette Foucher; Le Bail Brigitte
Journal:  J Hepatol       Date:  2013-12-28       Impact factor: 25.083

6.  A concordance correlation coefficient to evaluate reproducibility.

Authors:  L I Lin
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

Review 7.  The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan.

Authors:  M Sasso; V Miette; L Sandrin; M Beaugrand
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-09-15       Impact factor: 2.947

8.  Determination of reliability criteria for liver stiffness evaluation by transient elastography.

Authors:  Jérôme Boursier; Jean-Pierre Zarski; Victor de Ledinghen; Marie-Christine Rousselet; Nathalie Sturm; Brigitte Lebail; Isabelle Fouchard-Hubert; Yves Gallois; Frédéric Oberti; Sandrine Bertrais; Paul Calès
Journal:  Hepatology       Date:  2013-02-04       Impact factor: 17.425

9.  Differential effect of gender on hepatic fat.

Authors:  Vicente Gilsanz; Sandra A Chung; Neil Kaplowitz
Journal:  Pediatr Radiol       Date:  2011-03-15

10.  Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.

Authors:  Victor de Lédinghen; Julien Vergniol; Juliette Foucher; Wassil Merrouche; Brigitte le Bail
Journal:  Liver Int       Date:  2012-07       Impact factor: 5.828

View more
  10 in total

1.  Correlation between hepatorenal index and attenuation imaging for assessing hepatic steatosis.

Authors:  Shrivuthsun Srigandan; Marilyn Zelesco; Steven Abbott; Christopher J Welman
Journal:  Australas J Ultrasound Med       Date:  2022-07-01

Review 2.  Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD.

Authors:  Nobuharu Tamaki; Veeral Ajmera; Rohit Loomba
Journal:  Nat Rev Endocrinol       Date:  2021-11-23       Impact factor: 47.564

Review 3.  The Use of Transient Elastography Technology in the Bariatric Patient: a Review of the Literature.

Authors:  Max M Puthenpura; Vishal Patel; John Fam; Leon Katz; David S Tichansky; Stephan Myers
Journal:  Obes Surg       Date:  2020-09-26       Impact factor: 4.129

Review 4.  Application of transient elastography in nonalcoholic fatty liver disease.

Authors:  Xinrong Zhang; Grace Lai-Hung Wong; Vincent Wai-Sun Wong
Journal:  Clin Mol Hepatol       Date:  2019-11-08

Review 5.  Ultrasound-based techniques for the diagnosis of liver steatosis.

Authors:  Giovanna Ferraioli; Livia Beatriz Soares Monteiro
Journal:  World J Gastroenterol       Date:  2019-10-28       Impact factor: 5.742

6.  Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard.

Authors:  Giovanna Ferraioli; Laura Maiocchi; Maria Vittoria Raciti; Carmine Tinelli; Annalisa De Silvestri; Mara Nichetti; Pasquale De Cata; Mariangela Rondanelli; Luca Chiovato; Fabrizio Calliada; Carlo Filice
Journal:  Clin Transl Gastroenterol       Date:  2019-10       Impact factor: 4.488

Review 7.  Controlled Attenuation Parameter for Quantification of Steatosis: Which Cut-Offs to Use?

Authors:  Roxana Sirli; Ioan Sporea
Journal:  Can J Gastroenterol Hepatol       Date:  2021-03-26

Review 8.  Quantitative Evaluation of Hepatic Steatosis Using Advanced Imaging Techniques: Focusing on New Quantitative Ultrasound Techniques.

Authors:  Junghoan Park; Jeong Min Lee; Gunwoo Lee; Sun Kyung Jeon; Ijin Joo
Journal:  Korean J Radiol       Date:  2022-01       Impact factor: 3.500

Review 9.  Non-invasive diagnosis and staging of non-alcoholic fatty liver disease.

Authors:  Stergios Kechagias; Mattias Ekstedt; Christian Simonsson; Patrik Nasr
Journal:  Hormones (Athens)       Date:  2022-06-04       Impact factor: 3.419

Review 10.  Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens).

Authors:  Giovanna Ferraioli
Journal:  J Med Ultrason (2001)       Date:  2021-06-16       Impact factor: 1.314

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.